News

FDA commissioner stirs debate over hormone therapy for menopause

A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...

Women’s health care lacks funding, research, FDA chief says

Food and Drug Administration Commissioner Marty Makary has taken a personal interest in addressing hormone therapy treatment ...
BizPac Review5d

‘All of us are begging’: New push for FDA to remove ‘black box’ warnings from menopause products

The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

What the Government Says vs. How Women Actually Feel About Menopause

The contrast between the FDA’s clinical lens and the raw realities in the Bonafide study highlights a critical disconnect ...

A name to remember

A NAME YOU WILL REMEMBER: There can be a temptation in Washington-centric journalism to focus on those people with power. This morning, the most important thing you can read is about someone who had ...

Memo advises GOP to extend ACA tax credits

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Memo warns GOP not to let ObamaCare tax ...
Her Agenda on MSN2d

F.D.A. Discusses Removal Of Most Severe Warning On Menopause Treatments

At a recent U.S. Food and Drug Administration (F.D.A.) panel, doctors argued for the removal of the black box warning on hormone treatments used to alleviate menopause symptoms. The black box warning ...